Clinical and metabolic features of overdosage with Amesec.
A 23-year-old woman ingested 2g. amylobarbitone, 10.4g. aminophylline and 2g. ephedrine. She was deeply unconscious, hypothermic, and went on to have supraventricular and ventricular dysrhythmias, convulsions and haematemesis. During the last convulsion she aspirated vomitus and died. The peak plasma concentration of amylobarbitone was 19mg. per l. and those of ephedrine and theophylline were 13 times higher than accepted therapeutic levels. During the course of the poisoning marked hypokalaemia (1.8mmol./l.) and hyperinsulinaemia (greater than 240mU./l.) were found in conjunction with mild hyperglycaemia (9.6mmol./l.) and elevation of free fatty acid levels (1860mumol./l.). The mechanism of these changes is discussed.
D000328:Adult; D000628:Aminophylline / Q000506:poisoning*; D000654:Amobarbital / Q000506:poisoning*; D004338:Drug Combinations; D004562:Electrocardiography; D004809:Ephedrine / Q000506:poisoning*; D005069:Evaluation Studies as Topic; D005260:Female; D006323:Heart Arrest / Q000150:complications; D006801:Humans; D006985:Hyperventilation / Q000150:complications; D001239:Inhalation; D012640:Seizures / Q000150:complications; D013405:Suicide; D013610:Tachycardia / Q000150:complications; D014474:Unconsciousness / Q000139:chemically induced* / Q000150:complications; D014693:Ventricular Fibrillation / Q000150:complications
D004338:Drug Combinations; D000628:Aminophylline; D004809:Ephedrine; D000654:Amobarbital